Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

merz pharma uk ltd - botulinum toxin type a - powder for solution for injection - 50unit

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

merz pharma uk ltd - botulinum toxin type a - powder for solution for injection - 50unit

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

merz pharma uk ltd - botulinum toxin type a - powder for solution for injection - 100unit

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd - incobotulinumtoxina, quantity: 100 u - injection, powder for - excipient ingredients: albumin; sucrose - xeomin is indicated in adults for the treatment of:,? cervical dystonia (spasmodic torticollis),? blepharospasm,? spasticity of the upper limb,? chronic sialorrhea due to neurological disorders,? upper facial lines,- glabellar frown lines,- lateral periorbital lines (crow?s feet),- horizontal forehead lines,xeomin is indicated in children and adolescents aged 2 years to 17 years for the symptomatic treatment of:,? chronic sialorrhea due to neurological/neurodevelopmental disorders,? spasticity of the lower and/or upper limbs

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd - incobotulinumtoxina, quantity: 50 u - injection, powder for - excipient ingredients: albumin; sucrose - xeomin is indicated in adults for the treatment of:,? cervical dystonia (spasmodic torticollis),? blepharospasm,? spasticity of the upper limb,? chronic sialorrhea due to neurological disorders,? upper facial lines,- glabellar frown lines,- lateral periorbital lines (crow?s feet),- horizontal forehead lines,xeomin is indicated in children and adolescents aged 2 years to 17 years for the symptomatic treatment of:,? chronic sialorrhea due to neurological/neurodevelopmental disorders,? spasticity of the lower and/or upper limbs

Сінгапур - англійська - HSA (Health Sciences Authority)

merz asia pacific pte. ltd. - clostridium botulinum neurotoxin type a (150 kda), free from complexing proteins - injection, powder, for solution - 100 ld50 units - clostridium botulinum neurotoxin type a (150 kda), free from complexing proteins 100 ld50 units

Сінгапур - англійська - HSA (Health Sciences Authority)

merz asia pacific pte. ltd. - clostridium botulinum neurotoxin type a (150 kda), free from complexing proteins - injection, powder, for solution - 50 ld50 units - clostridium botulinum neurotoxin type a (150 kda), free from complexing proteins 50 ld50 units

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

merz pharma uk ltd - botulinum toxin type a - powder for solution for injection - 100unit

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

merz pharma uk ltd - botulinum toxin type a - powder for solution for injection - 200unit

Європейський Союз - англійська - EMA (European Medicines Agency)

merz pharmaceuticals gmbh - memantine hydrochloride - alzheimer disease - other anti-dementia drugs - treatment of patients with moderate to severe alzheimer's disease.